Trial Profile
A study to assess the efficacy, safety, pharmacokinetics and related genetic polymorphisms of sunitinib
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2014
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- 31 Oct 2014 New trial record